Dietary inorganic nitrate: From villain to hero in metabolic disease?

Molecular Nutrition and Food Research

Volumn 60, Issue 1, 2016, Pages 67-78

  Mcnally, Ben ^a,b   Griffin, Julian L ^a,b   Roberts, Lee D ^a,b  

^a MEDICAL RESEARCH COUNCIL   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Adipose Tissue; Diabetes; Dietary inorganic nitrate; Metabolic disease; Metabolism; Nitric oxide; Obesity

Indexed keywords

INDUCIBLE NITRIC OXIDE SYNTHASE; NITRIC ACID DERIVATIVE; NITRIC OXIDE; NITRITE; NOS2 PROTEIN, HUMAN;

ADIPOSE TISSUE; BIOAVAILABILITY; BLOOD; DIABETES MELLITUS, TYPE 2; DIET; DRUG EFFECTS; GENETICS; HEART; HUMAN; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; METABOLISM; OBESITY; PHYSIOLOGY;

ADIPOSE TISSUE; BIOLOGICAL AVAILABILITY; DIABETES MELLITUS, TYPE 2; DIET; HEART; HUMANS; HYPERTENSION; INFLAMMATION; METABOLIC SYNDROME X; NITRATES; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; NITRITES; OBESITY;

EID: 84952989245     PISSN: 16134125     EISSN: 16134133     Source Type: Journal    
DOI: 10.1002/mnfr.201500153     Document Type: Review

References (130)

1. Grosse, Y., Baan, R., Straif, K., Secretan, B. et al., Carcinogenicity of nitrate, nitrite, and cyanobacterial peptide toxins. Lancet Oncol. 2006, 7(8), 628-629.
2. International Agency for Research on Cancer, IARC monographs on the evaluation of carcinogenic risks to humans. Ingested nitrate and nitrite, and cyanobacterial peptide toxins. IARC Monogr. Eval. Carcinog. Risks Hum. 2010, 94, 1-412.
3. Buiatti, E., Palli, D., Decarli, A., Amadori, D. et al., A case-control study of gastric cancer and diet in Italy: II. Association with nutrients. Int. J. Cancer. 1990, 45(5), 896-901.
4. Mayne, S. T., Risch, H. A., Dubrow, R., Chow, W. H. et al., Nutrient intake and risk of subtypes of esophageal and gastric cancer. Cancer Epidemiol. Biomarkers Prev. 2001, 10(10), 1055-1062.
5. Toxicology and carcinogenesis studies of sodium nitrite (CAS NO. 7632-00-0) in F344/N rats and B6C3F1 mice (drinking water studies). Natl. Toxicol. Program Tech. Rep. Ser. 2001, 495, 7-273.
6. Greenblatt, M., Mirvish, S., So, B. T., Nitrosamine studies: induction of lung adenomas by concurrent administration of sodium nitrite and secondary amines in Swiss mice. J. Natl. Cancer Inst. 1971, 46, 1029-1034.
7. Lijinsky, W., Induction of tumours in rats by feeding nitrosatable amines together with sodium nitrite. Food Chem. Toxicol. 1984, 22, 715-720.
8. Swann, P. F., Magee, P. N., Nitrosamine-induced carcinogenesis. The alklylation of nucleic acids of the rat by N-methyl-N-nitrosourea, dimethylnitrosamine, dimethyl sulphate and methyl methanesulphonate. Biochem. J. 1968, 110, 39-47.
9. Bryan, N. S., Alexander, D. D., Coughlin, J. R., Milkowski, A. L. et al., Ingested nitrate and nitrite and stomach cancer risk: an updated review. Food Chem. Toxicol. 2012, 50, 3646-3665.
10. Jakszyn, P., Bingham, S., Pera, G., Agudo, A. et al., Endogenous versus exogenous exposure to N-nitroso compounds and gastric cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC-EURGAST) study. Carcinogenesis 2006, 27, 1497-1501.
11. Cross, A. J., Freedman, N. D., Ren, J., Ward, M. H. et al., Meat consumption and risk of esophageal and gastric cancer in a large prospective study. Am. J. Gastroenterol. 2011, 106, 432-442.
12. Jakszyn, P., Gonzalez, C.-A., Nitrosamine and related food intake and gastric and oesophageal cancer risk: a systematic review of the epidemiological evidence. World J. Gastroenterol. 2006, 12, 4296-4303.
13. Feskens, E. J. M., Sluik, D., van Woudenbergh, G. J., Meat consumption, diabetes, and its complications. Curr. Diab. Rep. 2013, 13(2), 298-306.
14. Micha, R., Wallace, S. K., Mozaffarian, D., Red and processed meat consumption and risk of incident coronary heart disease, stroke, and diabetes mellitus: a systematic review and meta-analysis. Circulation 2010, 121, 2271-2283.
15. Key, T. J., Fraser, G. E., Thorogood, M., Appleby, P. N. et al., Mortality in vegetarians and non-vegetarians: a collaborative analysis of 8300 deaths among 76, 000 men and women in five prospective studies. Public Health Nutr. 1998, 1, 33-41.
16. Wang, X., Ouyang, Y., Liu, J., Zhu, M. et al., Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies. BMJ 2014, 349, g4490.
17. Bazzano, L. A., He, J., Ogden, L. G., Loria, C. M. et al., Fruit and vegetable intake and risk of cardiovascular disease in US adults: the first National Health and Nutrition Examination Survey Epidemiologic Follow-up Study. Am. J. Clin. Nutr. 2002, 76, 93-99.
18. Ness, A. R., Powles, J. W., Fruit and vegetables, and cardiovascular disease: a review. Int. J. Epidemiol. 1997, 26, 1-13.
19. Hord, N. G., Tang, Y., Bryan, N. S., Food sources of nitrates and nitrites: the physiologic context for potential health benefits. Am. J. Clin. Nutr. 2009, 90, 1-10.
20. Lundberg, J. O., Weitzberg, E., Lundberg, J. M., Alving, K., Intragastric nitric oxide production in humans: measurements in expelled air. Gut 1994, 35, 1543-1546.
21. Zweier, J. L., Wang, P., Samouilov, A., Kuppusamy, P., Enzyme-independent formation of nitric oxide in biological tissues. Nat. Med. 1995, 1, 804-809.
22. Lundberg, J. O., Govoni, M., Inorganic nitrate is a possible source for systemic generation of nitric oxide. Free Radic. Biol. Med. 2004. 37, 395-400.
23. Lundberg, J. O., Carlström, M., Larsen, F. J., Weitzberg, E., Roles of dietary inorganic nitrate in cardiovascular health and disease. Cardiovasc. Res. 2011, 89(3), 525-532.
24. Lundberg, J. O., Weitzberg, E., Gladwin, M. T., The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat. Rev. Drug Discov. 2008, 7, 156-167.
25. Antosova, M., Nitric oxide-important messenger in human body. Open J. Mol. Integr. Physiol. 2012, 02, 98-106.
26. Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E. et al., Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc. Natl. Acad. Sci. USA 1987, 84, 9265-9269.
27. Palmer, R. M., Ferrige, A. G., Moncada, S., Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327, 524-526.
28. Loscalzo, J., Welch, G., Nitric oxide and its role in the cardiovascular system. Prog. Cardiovasc. Dis. 1995, 38, 87-104.
29. Calabrese, V., Mancuso, C., Calvani, M., Rizzarelli, E. et al., Nitric oxide in the central nervous system: neuroprotection versus neurotoxicity. Nat. Rev. Neurosci. 2007, 8, 766-775.
30. Bogdan, C., Nitric oxide and the immune response. Nat. Immunol. 2001, 2, 907-916.
31. Andrew, P., Enzymatic function of nitric oxide synthases, Cardiovasc. Res. 1999, 43(3), 521-531.
32. Griffith, O. W., Stuehr, D. J., Nitric oxide synthases: properties and catalytic mechanism. Annu. Rev. Physiol. 1995, 57, 707-736.
33. Bartholomew, B., Hill, M. J., The pharmacology of dietary nitrate and the origin of urinary nitrate. Food Chem. Toxicol. 1984, 22(10), 789-795.
34. Spiegelhalder, B., Eisenbrand, G., Preussmann, R., Influence of dietary nitrate on nitrite content of human saliva: possible relevance to in vivo formation of N-nitroso compounds. Food Cosmet. Toxicol. 1976, 14(6), 545-548.
35. Duncan, C., Dougall, H., Johnston, P., Green, S. et al., Chemical generation of nitric oxide in the mouth from the enterosalivary circulation of dietary nitrate, Nat. Med. 1995, 1(6), 546-551.
36. Benjamin, N., O'Driscoll, F., Dougall, H., Duncan, C. et al., Stomach NO synthesis. Nature 1994, 368(6471), 502.
37. Peri, L., Pietraforte, D., Scorza, G., Napolitano, A. et al., Apples increase nitric oxide production by human saliva at the acidic pH of the stomach: a new biological function for polyphenols with a catechol group? Free Radic. Biol. Med. 2005, 39(5), 668-681.
38. Gago, B., Lundberg, J. O., Barbosa, R. M., Laranjinha, J., Red wine-dependent reduction of nitrite to nitric oxide in the stomach. Free Radic. Biol. Med. 2007, 43(9), 1233-1242.
39. Jansson, E. A., Huang, L., Malkey, R., Govoni, M. et al., A mammalian functional nitrate reductase that regulates nitrite and nitric oxide homeostasis. Nat. Chem. Biol. 2008, 4(7), 411-417.
40. Ward, F. W., Coates, M. E., Cole, C. B., Fuller, R., Effect of dietary fats on endogenous formation of N-nitrosamines from nitrate in germ-free and conventional rats and rats harbouring a human flora. Food Addit. Contam. 1990, 7, 597-604.
41. Alikulov, Z. A., L'vov, N. P., Kretovich, V. L., Nitrate and nitrite reductase activity of milk xanthine oxidase. Biokhimii(combining double inverted breve)a 1980, 45, 1714-1718.
42. Millar, T. M., Stevens, C. R., Benjamin, N., Eisenthal, R. et al., Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 1998, 427, 225-228.
43. Li, H., Samouilov, A., Liu, X., Zweier, J. L., Characterization of the magnitude, kinetics of xanthine oxidase-catalyzed nitrate reduction: evaluation of its role in nitrite, nitric oxide generation in anoxic tissues. Biochemistry 2003, 42, 1150-1159.
44. Govoni, M., Jansson, E. A., Weitzberg, E., Lundberg, J. O., The increase in plasma nitrite after a dietary nitrate load is markedly attenuated by an antibacterial mouthwash. Nitric Oxide 2008, 19, 333-337.
45. Cosby, K., Partovi, K. S., Crawford, J. H., Patel, R. P. et al., Nitrite reduction to nitric oxide by deoxyhemoglobin vasodilates the human circulation. Nat. Med. 2003, 9, 1498-1505.
46. Shiva, S., Huang, Z., Grubina, R., Sun, J. et al., Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ. Res. 2007, 100, 5, 654-661.
47. Rassaf, T., Preik, M., Kleinbongard, P., Lauer, T. et al., Evidence for in vivo transport of bioactive nitric oxide in human plasma. J. Clin. Invest. 2002, 109, 1241-1248.
48. Totzeck, M., Hendgen-Cotta, U. B., Luedike, P., Berenbrink, M. et al., Nitrite regulates hypoxic vasodilation via myoglobin-dependent nitric oxide generation. Circulation 2012, 126, 325-334.
49. Nohl, H., Staniek, K., Sobhian, B., Bahrami, S. et al., Mitochondria recycle nitrite back to the bioregulator nitric monoxide. Acta Biochim. Pol. 2000, 47, 913-921.
50. Castello, P. R., David, P. S., McClure, T., Crook, Z. et al., Mitochondrial cytochrome oxidase produces nitric oxide under hypoxic conditions: implications for oxygen sensing and hypoxic signaling in eukaryotes. Cell Metab. 2006, 3, 277-287.
51. Kozlov, A. V., Staniek, K., Nohl, H., Nitrite reductase activity is a novel function of mammalian mitochondria. FEBS Lett. 1999, 454, 127-130.
52. Kelm, M., Nitric oxide metabolism and breakdown. Biochim. Biophys. Acta - Bioenerg. 1999, 1411, 273-289.
53. Maher, A. R., Milsom, A. B., Gunaruwan, P., Abozguia, K. et al., Hypoxic modulation of exogenous nitrite-induced vasodilation in humans. Circulation 2008, 117, 670-677.
54. Gladwin, M. T., Evidence mounts that nitrite contributes to hypoxic vasodilation in the human circulation. Circulation 2008, 117, 594-597.
55. Roberts, L. D., Ashmore, T., Kotwica, A. O., Murfitt, S. A. et al., Inorganic nitrate promotes the browning of white adipose tissue through the nitrate-nitrite-nitric oxide pathway. Diabetes 2014, 64, 471-484.
56. Huang, L., Borniquel, S., Lundberg, J. O., Enhanced xanthine oxidoreductase expression and tissue nitrate reduction in germ free mice. Nitric Oxide 2010, 22, 191-195.
57. Huang, P. L., A comprehensive definition for metabolic syndrome. Dis. Model. Mech. 2009, 2, 231-237.
58. Eckel, R. H., Grundy, S. M., Zimme, P. Z., The metabolic syndrome. Lancet 2005, 365, 1415-1428.
59. Danaei, G., Finucane, M. M., Lu, Y., Singh, G. M. et al., National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2·7 million participants. Lancet 2011, 378, 31-40.
60. Virtue, S. and Vidal-Puig, A., Adipose tissue expandability, lipotoxicity and the metabolic syndrome-an allostatic perspective. Biochim. Biophys. Acta 2010, 1801, 338-349.
61. Randle, P. J., Garland, P. B., Hales, C. N., Newsholme, E. A., The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963, 1, 785-789.
62. Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K. et al., Free fatty acid-induced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48, 1270-1274.
63. Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E. et al., Effects of free fatty acids on glucose transport and IRS-1-associated phosphatidylinositol 3-kinase activity. J. Clin. Invest. 1999, 103, 253-259.
64. Huang, P. L., eNOS, metabolic syndrome and cardiovascular disease. Trends Endocrinol. Metab. 2009, 20, 295-302.
65. Monti, L. D., Barlassina, C., Citterio, L., Galluccio, E. et al., Endothelial nitric oxide synthase polymorphisms are associated with type 2 diabetes and the insulin resistance syndrome. Diabetes 2003, 52, 1270-1275.
66. Siervo, M., Jacksonv, Bluck, L. J. C., In-vivo nitric oxide synthesis is reduced in obese patients with metabolic syndrome: application of a novel stable isotopic method. J. Hypertens. 2011, 29, 1515-1527.
67. Cook, S., Hugli, O., Egli, M., Vollenweider, P. et al., Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice. Swiss Med. Wkly. 2003, 133, 360-363.
68. Duplain, H., Burcelin, R., Sartori, C., Cook, S. et al., Insulin resistance, hyperlipidemia, and hypertension in mice lacking endothelial nitric oxide synthase. Circulation 2001, 104, 342-345.
69. Carlström, M., Larsen, F. J., Nyström, T., Hezel, M. et al., Dietary inorganic nitrate reverses features of metabolic syndrome in endothelial nitric oxide synthase-deficient mice. Proc. Natl. Acad. Sci. USA 2010, 107, 17716-17720.
70. Duncan, R. E., Ahmadian, M., Jaworski, K., Sarkadi-Nagy, E. et al., Regulation of lipolysis in adipocytes. Annu. Rev. Nutr. 2007, 27, 79-101.
71. Saely, C. H., Geiger, K., Drexel, H., Brown versus white adipose tissue: a mini-review. Gerontology 2012, 58, 15-23.
72. Cannon, B., Nedergaard, J., Brown adipose tissue: function and physiological significance. Physiol. Rev. 2004, 84, 277-359.
73. Fedorenko, A., Lishko, P. V., Kirichok, Y., Mechanism of fatty-acid-dependent UCP1 uncoupling in brown fat mitochondria. Cell 2012, 151, 400-413.
74. Kopecky, J., Clarke, G., Enerbäck, S., Spiegelman, B. et al., Expression of the mitochondrial uncoupling protein gene from the aP2 gene promoter prevents genetic obesity. J. Clin. Invest. 1995, 96, 2914-2923.
75. Lowell, B. B., S-Susulic, V., Hamann, A., Lawitts, J. A. et al., Development of obesity in transgenic mice after genetic ablation of brown adipose tissue. Nature 1993, 366, 740-742.
76. Pfannenberg, C., Werner, M. K., Ripkens, S., Stef, I. et al., Impact of age on the relationships of brown adipose tissue with sex and adiposity in humans. Diabetes 2010, 59, 1789-1793.
77. Young, P., Arch, J. R., Ashwell, M., Brown adipose tissue in the parametrial fat pad of the mouse. FEBS Lett. 1984, 167, 10-14.
78. Wu, J., Boström, P., Sparks, L. M., Ye, L. et al., Beige adipocytes are a distinct type of thermogenic fat cell in mouse and human. Cell 2012, 150, 366-376.
79. Ghorbani, M., Claus, T. H., Himms-Hagen, J., Hypertrophy of brown adipocytes in brown and white adipose tissues and reversal of diet-induced obesity in rats treated with a beta3-adrenoceptor agonist. Biochem. Pharmacol. 1997, 54, 121-131.
80. Bordicchia, M., Liu, D., Amri, E.-Z., Ailhaud, G. et al., Cardiac natriuretic peptides act via p38 MAPK to induce the brown fat thermogenic program in mouse and human adipocytes. J. Clin. Invest. 2012, 122, 1022-1036.
81. Fisher, F. M., Kleiner, S., Douris, N., Fox, E. C. et al., FGF21 regulates PGC-1α and browning of white adipose tissues in adaptive thermogenesis. Genes Dev. 2012, 26, 271-281.
82. Boström, P., Wu, J., Jedrychowski, M. P., Korde, A. et al., A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis. Nature 2012, 481, 463-468.
83. Roberts, L. D., Boström, P., O'Sullivan, J. F., Schinzel, R. T. et al., β-Aminoisobutyric acid induces browning of white fat and hepatic β-oxidation and is inversely correlated with cardiometabolic risk factors. Cell Metab. 2014, 19, 96-108.
84. Wu, J., Cohen, P., Spiegelman, B. M., Adaptive thermogenesis in adipocytes: is beige the new brown? Genes Dev. 2013, 27, 234-250.
85. Kapil, V., Milsom, A. B., Okorie, M., Maleki-Toyserkani, S. et al., Inorganic nitrate supplementation lowers blood pressure in humans: role for nitrite-derived NO. Hypertension 2010, 56, 274-281.
86. Bryan, N. S., Fernandez, B. O., Bauer, S. M., Garcia-Saura, M. F. et al., Nitrite is a signaling molecule and regulator of gene expression in mammalian tissues. Nat. Chem. Biol. 2005, 1, 290-297.
87. Katafuchi, T., Garbers, D. L., Albanesi, J. P., CNP/GC-B system: a new regulator of adipogenesis. Peptides 2010, 31, 1906-1911.
88. Nishikimi, T., Iemura-Inaba, C., Akimoto, K., Ishikawa, K. et al., Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes. Regul. Pept. 2009, 153, 56-63.
89. Zhang, X., Ji, J., Yan, G., Wu, J. et al., Sildenafil promotes adipogenesis through a PKG pathway. Biochem. Biophys. Res. Commun. 2010, 396, 1054-1059.
90. Mitschke, M. M., Hoffmann, L. S., Gnad, T., Scholz, D. et al., Increased cGMP promotes healthy expansion and browning of white adipose tissue. FASEB J. 2013, 27, 1621-1630.
91. Hosogai, N., Fukuhara, A., Oshima, K., Miyata, Y. et al., Adipose tissue hypoxia in obesity and its impact on adipocytokine dysregulation. Diabetes 2007, 56, 901-911.
92. Kabon, B., Nagele, A., Reddy, D., Eagon, C. et al., Obesity decreases perioperative tissue oxygenation. Anesthesiology 2004, 100, 274-280.
93. Ye, J., Gao, Z., Yin, J., He, Q., Hypoxia is a potential risk factor for chronic inflammation and adiponectin reduction in adipose tissue of ob/ob and dietary obese mice. Am. J. Physiol. Endocrinol. Metab. 2007, 293, E1118-E1128.
94. Sowers, J. R., Epstein, M., Frohlich, E. D., Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001, 37, 1053-1059.
95. Krause, T., Lovibond, K., Caulfield, M., McCormack, T. et al., Management of hypertension: summary of NICE guidance. BMJ 2011, 343, d4891.
96. Wang, W., Lee, E. T., Fabsitz, R. R., Devereux, R. et al., A longitudinal study of hypertension risk factors and their relation to cardiovascular disease: the Strong Heart Study. Hypertension 2006, 47, 403-409.
97. Collins, R., Peto, R., MacMahon, S., Hebert, P. et al., Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet 1990, 335, 827-838.
98. Hansson, L., Lindholm, L. H., Niskanen, L., Lanke, J. et al., Effect of angiotensin-converting-enzyme inhibition compared with conventional therapy on cardiovascular morbidity and mortality in hypertension: the Captopril Prevention Project (CAPPP) randomised trial. Lancet 1999, 353, 611-616.
99. Yusuf, S., Sleight, P., Pogue, J., Bosch, J. et al., Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N. Engl. J. Med. 2000, 342, 145-153.
100. Centers for Disease Control and Prevention, National Diabetes Fact Sheet, 2011.
101. Puddu, P., Puddu, G. M., Zaca, F., Muscari, A., Endothelial dysfunction in hypertension. Acta Cardiol. 2000, 55, 221-232.
102. Cai, H., Harrison, D. G., Endothelial dysfunction in cardiovascular diseases: The role of oxidant stress. Circ. Res. 2000, 87, 840-844.
103. Cannon, R. O., Role of nitric oxide in cardiovascular disease: focus on the endothelium. Clin. Chem. 1998, 44, 1809-1819.
104. Hobbs, D. A., George, T. W., Lovegrove, J. A., The effects of dietary nitrate on blood pressure and endothelial function: a review of human intervention studies. Nutr. Res. Rev. 2013, 26, 210-222.
105. Webb, A. J., Patel, N., Loukogeorgakis, S., Okorie, M. et al., Acute blood pressure lowering, vasoprotective, and antiplatelet properties of dietary nitrate via bioconversion to nitrite. Hypertension 2008, 51, 784-790.
106. Kenjale, A. A., Ham, K. L., Stabler, T., Robbins, J. L. et al., Dietary nitrate supplementation enhances exercise performance in peripheral arterial disease. J. Appl. Physiol. 2011, 110, 1582-1591.
107. Ghosh, S. M., Kapil, V., Fuentes-Calvo, I., Bubb, K. J. et al., Enhanced vasodilator activity of nitrite in hypertension: critical role for erythrocytic xanthine oxidoreductase and translational potential. Hypertension 2013, 61, 1091-1102.
108. Kapil, V., Khambata, R. S., Robertson, A., Caulfield, M. J. et al., Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study. Hypertension 2015, 65, 320-327.
109. Wilcox, C. S., Oxidative stress and nitric oxide deficiency in the kidney: a critical link to hypertension? Am. J. Physiol. Regul. Integr. Comp. Physiol. 2005, 289, R913-R935.
110. Patzak, A., Persson, A. E. G., Angiotensin II-nitric oxide interaction in the kidney. Curr. Opin. Nephrol. Hypertens. 2007, 16, 46-51.
111. Gao, X., Yang, T., Liu, M., Peleli, M. et al., NADPH oxidase in the renal microvasculature is a primary target for blood pressure-lowering effects by inorganic nitrate and nitrite. Hypertension 2014, 65, 161-170.
112. Datla, S. R., Griendling, K. K., Reactive oxygen species, NADPH oxidases, and hypertension. Hypertension 2010, 56, 325-330.
113. Ashmore, T., Fernandez, B. O., Evans, C. E., Huang, Y. et al., Suppression of erythropoiesis by dietary nitrate. FASEB J. 2014, 29, 1102-1112.
114. Eckardt, K. U., Ratcliffe, P. J., Tan, C. C., Bauer, C. et al., Age-dependent expression of the erythropoietin gene in rat liver and kidneys. J. Clin. Invest. 1992, 89, 753-760.
115. Jae, S. Y., Kurl, S., Laukkanen, J. A., Heffernan, K. S. et al., Higher blood hematocrit predicts hypertension in men. J. Hypertens. 2014, 32, 245-250.
116. Liu, X., Liang, J., Qiu, Q., Zhu, Y. et al., Association of hematocrit and pre-hypertension among Chinese adults: the CRC Study. Cell Biochem. Biophys. 2015, 71, 1123-1128.
117. Joshipura, K. J., Hu, F. B., Manson, J. E., Stampfer, M. J. et al., The effect of fruit and vegetable intake on risk for coronary heart disease. Ann. Intern. Med. 2001, 134, 1106-1114.
118. Holloway, C. J., Montgomery, H. E., Murray, A. J., Cochlin, L. E. et al., Cardiac response to hypobaric hypoxia: persistent changes in cardiac mass, function, and energy metabolism after a trek to Mt. Everest base camp. FASEB J. 2011, 25, 792-796.
119. Heather, L. C., Cole, M. A., Tan, J.-J., Ambrose, L. J. A. et al., Metabolic adaptation to chronic hypoxia in cardiac mitochondria. Basic Res. Cardiol. 2012, 107, 268-280.
120. Ashmore, T., Fernandez, B. O., Branco-Price, C., West, J. A. et al., Dietary nitrate increases arginine availability and protects mitochondrial complex I and energetics in the hypoxic rat heart. J. Physiol. 2014, 592, 4715-4731.
121. Pernow, J., Jung, C., Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal? Cardiovasc. Res. 2013, 98, 334-343.
122. Willam, C., Maxwell, P. H., Nichols, L., Lygate, C. et al., HIF prolyl hydroxylases in the rat; organ distribution and changes in expression following hypoxia and coronary artery ligation. J. Mol. Cell. Cardiol. 2006, 41, 68-77.
123. Murray, A. J., Lygate, C. A., Cole, M. A., Carr, C. A. et al., Insulin resistance, abnormal energy metabolism and increased ischemic damage in the chronically infarcted rat heart. Cardiovasc. Res. 2006, 71, 149-157.
124. Murray, A. J., Cole, M. A., Lygate, C. A., Carr, C. A. et al., Increased mitochondrial uncoupling proteins, respiratory uncoupling and decreased efficiency in the chronically infarcted rat heart. J. Mol. Cell. Cardiol. 2008, 44, 694-700.
125. Esser, N., Legrand-Poels, S., Piette, J., Scheen, A. J. et al., Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res. Clin. Pract. 2014, 105, 141-150.
126. Monteiro, R., Azevedo, I., Chronic inflammation in obesity and the metabolic syndrome. Mediators Inflamm. 2010, 2010, doi: 10.1155/2010/289645.
127. Zamora, R., Vodovotz, Y., Billiar, T. R., Inducible nitric oxide synthase and inflammatory diseases. Mol. Med. 2000, 6, 347-373.
128. Sharma, J. N., Al-Omran, A., Parvathy, S. S., Role of nitric oxide in inflammatory diseases. Inflammopharmacology 2008, 15, 252-259.
129. Perreault, M., Marette, A., Targeted disruption of inducible nitric oxide synthase protects against obesity-linked insulin resistance in muscle. Nat. Med. 2001, 7, 1138-1143.
130. Yang, T., Peleli, M., Zollbrecht, C., Giulietti, A. et al., Inorganic nitrite attenuates NADPH oxidase-derived superoxide generation in activated macrophages via a nitric oxide-dependent mechanism. Free Radic. Biol. Med. 2015, 83, 159-166.